Imunon, Inc. (IMNN) stock
IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.61+0.02 (+3.06%)
Close on Nov 17, 2026Market cap $3.44MP/E –Yield –
Imunon cash
Cash and short-term investments held at the end of each period.
Imunon's cash was $4.80M at Mar 31, 2026. For fiscal 2025 it was $8.80M, up 49.2% from the year before. Over ten years it grew -7.9% a year on average. The highest annual figure on record is $56.90M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.80M | +49.2% |
| FY2024 | Dec 31, 2024 | $5.90M | -62.4% |
| FY2023 | Dec 31, 2023 | $15.70M | -52.1% |
| FY2022 | Dec 31, 2022 | $32.80M | -42.4% |
| FY2021 | Dec 31, 2021 | $56.90M | +231.5% |
| FY2020 | Dec 31, 2020 | $17.16M | +15.8% |
| FY2019 | Dec 31, 2019 | $14.82M | -46.3% |
| FY2018 | Dec 31, 2018 | $27.58M | +14.0% |
| FY2017 | Dec 31, 2017 | $24.20M | +462.8% |
| FY2016 | Dec 31, 2016 | $4.30M | -78.6% |
| FY2015 | Dec 31, 2015 | $20.07M | -45.6% |
| FY2014 | Dec 31, 2014 | $36.86M | -14.0% |
| FY2013 | Dec 31, 2013 | $42.87M | +86.2% |
| FY2012 | Dec 31, 2012 | $23.03M | -18.3% |
| FY2011 | Dec 31, 2011 | $28.18M | +1736.7% |
| FY2010 | Dec 31, 2010 | $1.53M | -77.8% |
| FY2009 | Dec 31, 2009 | $6.92M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | $4.80M | +65.5% |
| Q4 FY2025 | Dec 31, 2025 | $8.80M | +49.2% |
| Q3 FY2025 | Sep 30, 2025 | $5.30M | -48.5% |
| Q2 FY2025 | Jun 30, 2025 | $4.70M | -11.3% |
| Q1 FY2025 | Mar 31, 2025 | $2.90M | -70.4% |
| Q4 FY2024 | Dec 31, 2024 | $5.90M | -62.4% |
| Q3 FY2024 | Sep 30, 2024 | $10.30M | -47.2% |
| Q2 FY2024 | Jun 30, 2024 | $5.30M | -78.0% |
| Q1 FY2024 | Mar 31, 2024 | $9.80M | -70.1% |
| Q4 FY2023 | Dec 31, 2023 | $15.70M | -58.0% |
| Q3 FY2023 | Sep 30, 2023 | $19.50M | -59.5% |
| Q2 FY2023 | Jun 30, 2023 | $24.10M | -49.0% |
| Q4 FY2022 | Dec 31, 2022 | $32.80M | -42.4% |
| Q3 FY2022 | Sep 30, 2022 | $37.40M | -31.4% |
| Q2 FY2022 | Jun 30, 2022 | $48.10M | -17.6% |
| Q1 FY2022 | Mar 31, 2022 | $47.30M | -10.3% |
| Q4 FY2021 | Dec 31, 2021 | $56.90M | +231.5% |
| Q3 FY2021 | Sep 30, 2021 | $54.51M | +197.2% |
| Q2 FY2021 | Jun 30, 2021 | $58.36M | +129.4% |
| Q1 FY2021 | Mar 31, 2021 | $52.76M | +237.5% |
| Q4 FY2020 | Dec 31, 2020 | $17.16M | +15.8% |
| Q3 FY2020 | Sep 30, 2020 | $18.34M | -2.3% |
| Q2 FY2020 | Jun 30, 2020 | $25.44M | +17.7% |
| Q1 FY2020 | Mar 31, 2020 | $15.63M | -33.9% |
| Q4 FY2019 | Dec 31, 2019 | $14.82M | -46.3% |
| Q3 FY2019 | Sep 30, 2019 | $18.78M | -14.4% |
| Q2 FY2019 | Jun 30, 2019 | $21.62M | -17.5% |
| Q1 FY2019 | Mar 31, 2019 | $23.66M | +14.3% |
| Q4 FY2018 | Dec 31, 2018 | $27.58M | +14.0% |
| Q3 FY2018 | Sep 30, 2018 | $21.93M | +716.8% |
| Q2 FY2018 | Jun 30, 2018 | $26.20M | +622.0% |
| Q1 FY2018 | Mar 31, 2018 | $20.70M | +363.1% |
| Q4 FY2017 | Dec 31, 2017 | $24.20M | +462.8% |
| Q3 FY2017 | Sep 30, 2017 | $2.69M | -69.1% |
| Q2 FY2017 | Jun 30, 2017 | $3.63M | -74.9% |
| Q1 FY2017 | Mar 31, 2017 | $4.47M | -68.8% |
| Q4 FY2016 | Dec 31, 2016 | $4.30M | – |
| Q3 FY2016 | Sep 30, 2016 | $8.70M | – |
| Q2 FY2016 | Jun 30, 2016 | $14.47M | – |
| Q1 FY2016 | Mar 31, 2016 | $14.31M | – |
See a number that looks wrong?